New Delhi, Feb. 5 -- Amwill Healthcare initial public offering (IPO) opened for subscription on February 5. The small and medium enterprise (SME) issue has been subscribed 0.69 times so far on the first day of bidding.

Amwill is a derma-cosmetic development company that collaborates with contract manufacturers, distributors, and third-party product development agencies. These partnerships have helped the company build expertise in manufacturing, packaging, and distribution.

The Amwill Healthcare IPO has received 48,00,000 against offered 54,03,600 by 3:30 pm on February 5.

On the first day of bidding, the retail segment of the issue was subscribed 0.89 times, while non-institutional investors- and QIB categories were subscribed 0.39 ti...